Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 30,449 | 25,304 | 20,920 | 17,646 | 15,173 |
| Cost of Goods | 3,964 | 3,065 | 2,434 | 2,033 | 1,744 |
| Gross Profit | 26,485 | 22,239 | 18,486 | 15,613 | 13,429 |
| Operating Expenses | 29,617 | 29,458 | 27,931 | 21,806 | 23,388 |
| Operating Income | -2,168 | -7,154 | -9,011 | -6,160 | -9,215 |
| Interest Expense | 1,098 | 1,165 | 1,188 | 1,153 | 1,153 |
| Other Income | 0 | 0 | 0 | 58 | 0 |
| Pre-tax Income | -3,266 | -8,319 | -10,199 | -7,255 | -10,368 |
| Net Income Continuous | -3,266 | -8,319 | -10,199 | -7,255 | -10,368 |
| Net Income | $-3,266 | $-8,319 | $-10,199 | $-7,255 | $-10,368 |
| EPS Basic Total Ops | -0.09 | -0.24 | -0.30 | -0.12 | -0.30 |
| EPS Basic Continuous Ops | -0.09 | -0.24 | -0.30 | -0.13 | -0.30 |
| EPS Diluted Total Ops | -0.09 | -0.24 | -0.30 | -0.12 | -0.30 |
| EPS Diluted Continuous Ops | -0.09 | -0.24 | -0.30 | -0.13 | -0.30 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.24 | -0.30 | -0.21 | -0.30 |
| EBITDA(a) | $-2,157 | $-7,152 | $-8,922 | $-6,116 | $-9,157 |